Cargando…

Off-label use of drugs in regional anesthesia: A need for setting up policies

Detalles Bibliográficos
Autores principales:	Singh, Saru, Bansal, Pranav, Dureja, Jagdish
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Medknow Publications & Media Pvt Ltd 2017
Materias:	Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5791255/ https://www.ncbi.nlm.nih.gov/pubmed/29416234 http://dx.doi.org/10.4103/joacp.JOACP_341_15

Ejemplares similares

Off-label drugs use in pediatric palliative care
por: De Zen, Lucia, et al.
Publicado: (2018)

Safety Consequences of Off-Label Drugs Used for COVID-19
por: Dasgupta, Nabarun
Publicado: (2021)

Clinical expertise in regional anesthesia: Anesthesiologists voice their need for formal training
por: Souzdalnitski, Dmitri, et al.
Publicado: (2013)

Cladribine: Off-label disease modification for people with multiple sclerosis in resource-poor settings?
por: Mao, Zhifeng, et al.
Publicado: (2018)

Off-label drug promotion and the ephemeral line between marketing and education
por: Krause, Joan H.
Publicado: (2015)

In-/off-label use of biologic therapy in systemic lupus erythematosus
por: Gatto, Mariele, et al.
Publicado: (2014)

Thinking Systematically About the Off-Label Use of Cancer Drugs and Combinations for Patients Who Have Exhausted Proven Therapies
por: Mailankody, Sham, et al.
Publicado: (2016)

Food literacy & food labeling laws—a legal analysis of India’s food policy
por: Bera, Om Prakash, et al.
Publicado: (2023)

Make up a missed lesson‐New policy to ensure the interchangeability of generic drugs in China
por: Huang, Baobin, et al.
Publicado: (2017)

Challenges to implement minimum effective volume in regional anesthesia
por: Subramani, Sudhakar, et al.
Publicado: (2019)

How to set up a standard regional anesthesia service?
por: Mohammed, Al Harbi, et al.
Publicado: (2011)

Carrier detection in childhood: a need for policy reform
por: Ross, Lainie Friedman
Publicado: (2010)

Commentary: Office-based vitrectomy using topical anesthesia in an Indian setting
por: Mohan, Ashwin, et al.
Publicado: (2018)

Reshaping Australian drug policy: the dilemmas of generic medicines policy
por: Löfgren, Hans
Publicado: (2007)

Why Genetically Modified Food Need Reconsideration Before Consumption?
por: Grover, Alka, et al.
Publicado: (2014)

Is General Anesthesia Needed in Endoscopic Submucosal Dissection for Lesions Located in the Mid to Upper Stomach?
por: Mahawongkajit, Prasit, et al.
Publicado: (2022)

Drug utilization in neonatal setting of Pakistan: focus on unlicensed and off label drug prescribing
por: Aamir, Muhammad, et al.
Publicado: (2018)

Off-label drugs for obesity
por: Morgan, Andy, et al.
Publicado: (2022)

Indirect effects of the pandemic: highlighting the need for data-driven policy and preparedness
por: Banerjee, Amitava, et al.
Publicado: (2022)

Strengthening the policy setting process for global malaria control and elimination
por: D'Souza, Bianca J, et al.
Publicado: (2012)

Globalization of national surgical, obstetric and anesthesia plans: the critical link between health policy and action in global surgery
por: Truché, Paul, et al.
Publicado: (2020)

Off-label, but on target: the evidence needed to implement alternative dosing regimens of anticancer drugs
por: Overbeek, J.K., et al.
Publicado: (2023)

Correlation of quality of life scores to clinical outcome of lumbar epidural steroids in chronic low back pain
por: Singh, Saru, et al.
Publicado: (2016)

A feasibility study to assess vallecula and pyriform sinus using protocol-based ultrasonic evaluation of floor of mouth and upper airway
por: Singh, Kulvinder, et al.
Publicado: (2017)

Experience of setting up of Control room for COVID-19 at NCDC, New Delhi
por: Kaushal, Kanica, et al.
Publicado: (2021)

COVID-19: What we need from epidemiology to help informed policies
por: Wong, Xin Ci, et al.
Publicado: (2021)

Improving the distribution of FDI benefits: The need for policy-oriented research, advice, and advocacy
por: Sauvant, Karl P.
Publicado: (2021)

Managing Heterogeneity in Prescription Drug Coverage Policies
por: Teagarden, J. Russell
Publicado: (2014)

Is the Fixed-Dose Intravenous Trastuzumab Policy Warranted in Limited-Resource Settings?
por: Kassem, Loay, et al.
Publicado: (2019)

Gendered implications of the COVID-19 pandemic for policies and programmes in humanitarian settings
por: Fuhrman, Sarah, et al.
Publicado: (2020)

Is it time to separate consent for anesthesia from consent for surgery?
por: Singh, Tejinder Singh Swaran
Publicado: (2017)

An ethical analysis of UK drug policy as an example of a criminal justice approach to drugs: a commentary on the short film Putting UK Drug Policy into Focus
por: Holland, Adam
Publicado: (2020)

Rectal use of levetiracetam: best practice report for a stepwise approach for sustainable off-label decision making and treatment
por: Rémi, Constanze, et al.
Publicado: (2023)

Statutory Regulation of Traditional Medicine Practitioners and Practices: The Need for Distinct Policy Making Guidelines
por: Ijaz, Nadine, et al.
Publicado: (2018)

Insecure Employment Contracts during the COVID-19 Pandemic and the Need for Participation in Policy Making
por: Maleki, Maryam, et al.
Publicado: (2021)

Off-label drugs for weight management
por: Hendricks, Ed J
Publicado: (2017)

Off-Label Use vs Off-Label Marketing of Drugs: Part 1: Off-Label Use—Patient Harms and Prescriber Responsibilities
por: Van Norman, Gail A.
Publicado: (2023)

Drug procurement, the Global Fund and misguided competition policies
por: Tren, Richard, et al.
Publicado: (2009)

What’s Public? What’s Private?: Policy Trade-offs and the Debate Over Mandatory Annual Influenza Vaccination for Health Care Workers
por: Mah, Catherine L.
Publicado: (2008)

Regulating off-label drug use in India: The arena for concern
por: Oberoi, Sukhvinder Singh
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_8beglvjiv4tbhekh9pgs1a4fqu